Survey of the effect of memantine on negative sign in patients with schizophrenia and schizoaffective disorders

Authors

  • Abdollah Farhadi Nasab Associate Professor of Psychiatry, Behavioral Sciences Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran .
  • Ali Kheradmand Assistant Professor of psychiatry, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  • Hamide Abbaspour PhD Student of clinical pharmacy, Shahid Beheshti University of Medical Sciences , Tehran, Iran .
  • Maria Tavakoli-Ardakani Associate Professor of clinical pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran .
Abstract:

Aim: The aim of this study is to evaluate the effect of memantine on negative symptoms in patients with schizophrenia and schizoaffective. Methods: This is a double- blind randomized clinical trial. 58 patients participated in the study, 29 patients were randomly assigned to the memantine group and 29 patients to the placebo group. For assessing negative signs, and we used scale for the assessment of negative symptom (SANS) at baseline, week 4 and week 12. Participant were assigned to receive 5-20 mg /day memantine (n=29) or placebo (n=29) in addition to continuing treatment with antipsychotics for 12 weeks. The primary efficacy measure was the total score on the positive and negative symptoms (PANSS). Safety was assessed by means of physical examination, clinical laboratory evaluation, recording of adverse effects (AEs). Results: No significant difference in demographic or clinical variables were observed between two groups. At end point, mean score of scale for the assessment of negative symptoms (SANS) decreased significantly during the treatment with memantine in comparison to placebo. Conclusion: The result of this trial suggested that memantine can be effective in reducing negative symptoms in schizophrenia and schizoaffective.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

Effect of Memantine on Positive Sign in Patients with Schizophrenia and Schizoaffective Disorders: A Randomized Double Blind Placebo Controlled Trial

Background and purpose: Memantine is a medication used to treat moderate to severe Alzheimer’s disease. Memantine targeting the glutamatergic system specifically N-Methyl-D-Aspartate offer a novel approach in treatment of psychiatric disorders such as schizophrenia and schizoaffective disorder. The purpose of this study was to evaluate the efficacy and safety of memantine in combination with an...

full text

the washback effect of discretepoint vs. integrative tests on the retention of content in knowledge tests

در این پایان نامه تاثیر دو نوع تست جزیی نگر و کلی نگر بر به یادسپاری محتوا ارزیابی شده که نتایج نشان دهندهکارایی تستهای کلی نگر بیشتر از سایر آزمونها است

15 صفحه اول

the effect of taftan pozzolan on the compressive strength of concrete in the environmental conditions of oman sea (chabahar port)

cement is an essential ingredient in the concrete buildings. for production of cement considerable amount of fossil fuel and electrical energy is consumed. on the other hand for generating one tone of portland cement, nearly one ton of carbon dioxide is released. it shows that 7 percent of the total released carbon dioxide in the world relates to the cement industry. considering ecological issu...

: the effect of sericin levels (silk glue protein) on rate of in vitro maturation, fertilization and culture of sheep oocytes

هدف از آزمایش اول بررسی اثر سطوح مختلف سریسین [0 (control), 0.1, 0.5, 1.0, 2.5 %] افزوده شده به محیط , ivm بر cumulus cell expansion، بلوغ هسته و توسعه متوالی جنین، در گوسفندان نژاد سنجابی در فصل تولید مثلی می باشد. از سرگیری میوز به وسیله خارج شدن اولین پولار بادی اندازه گیری و هم چنین درصد رسیدن جنین های دو سلولی به مرحله کلیواژ و بلاستوسیت نیز به عنوان نشانه ای از میزان شایستگی توسعه اولیه ج...

My Resources

Save resource for easier access later

Save to my library Already added to my library

{@ msg_add @}


Journal title

volume 17  issue Special Issue

pages  122- 129

publication date 2018-03-01

By following a journal you will be notified via email when a new issue of this journal is published.

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023